Nanoparticles in Combating Neuronal Dysregulated Signaling Pathways: Recent Approaches to the Nanoformulations of Phytochemicals and Synthetic Drugs Against Neurodegenerative Diseases

References

• Moradi SZ, Momtaz S, Bayrami Z, Farzaei MH, Abdollahi M. Nanoformulations of herbal extracts in treatment of neurodegenerative disorders. Front Bioeng Biotechnol. 2020;8:238. doi:10.3389/fbioe.2020.00238
   PubMed Web of Science ®Google Scholar
• Kumar H, Bhardwaj K, Nepovimova E, et al. Antioxidant functionalized nanoparticles: a combat against oxidative stress. Nanomaterials. 2020;10(7):1334. doi:10.3390/nano10071334
   Web of Science ®Google Scholar
• Gupta J, Fatima MT, Islam Z, Khan RH, Uversky VN, Salahuddin P. Nanoparticle formulations in the diagnosis and therapy of Alzheimer’s disease. Int J Biol Macromol. 2019;130:515–526. doi:10.1016/j.ijbiomac.2019.02.156
   PubMed Web of Science ®Google Scholar
• Mechan A, Yuan J, Hatzidimitriou G, Irvine RJ, McCann UD, Ricaurte GA. Pharmacokinetic profile of single and repeated oral doses of MDMA in squirrel monkeys: relationship to lasting effects on brain serotonin neurons. Neuropsychopharmacology. 2006;31(2):339–350. doi:10.1038/sj.npp.1300808
   PubMed Web of Science ®Google Scholar
• Agarwal H, Nakara A, Shanmugam VK. Anti-inflammatory mechanism of various metal and metal oxide nanoparticles synthesized using plant extracts: a review. Biomed Pharmacother. 2019;109:2561–2572. doi:10.1016/j.biopha.2018.11.116
   PubMed Web of Science ®Google Scholar
• Fakhri S, Moradi SZ, Farzaei MH, Bishayee A. Modulation of Dysregulated Cancer Metabolism by Plant Secondary Metabolites: A Mechanistic Review. Elsevier; 2020.
   Google Scholar
• Ma -D-D, Yang W-X. Engineered nanoparticles induce cell apoptosis: potential for cancer therapy. Oncotarget. 2016;7(26):40882. doi:10.18632/oncotarget.8553
   PubMedGoogle Scholar
• Ross C, Taylor M, Fullwood N, Allsop D. Liposome delivery systems for the treatment of Alzheimer’s disease. Int J Nanomedicine. 2018;13:8507. doi:10.2147/IJN.S183117
   PubMed Web of Science ®Google Scholar
• Moghaddam RH, Samimi Z, Moradi SZ, Little PJ, Xu S, Farzaei MH. Naringenin and naringin in cardiovascular disease prevention: a preclinical review. Eur J Pharmacol. 2020;887:173535. doi:10.1016/j.ejphar.2020.173535
   PubMed Web of Science ®Google Scholar
• Fakhri S, Pesce M, Patruno A, et al. Attenuation of Nrf2/Keap1/ARE in Alzheimer’s disease by plant secondary metabolites: a mechanistic review. Molecules. 2020;25(21):4926. doi:10.3390/molecules25214926
   PubMed Web of Science ®Google Scholar
• Moradi SZ, Jalili F, Farhadian N, et al. Polyphenols and neurodegenerative diseases: focus on neuronal regeneration. Crit Rev Food Sci Nutr. 2020:1–16. doi:10.1080/10408398.2020.1865870
   Web of Science ®Google Scholar
• Milatovic D, Zaja-Milatovic S, Breyer RM, Aschner M, Montine TJ. Neuroinflammation and oxidative injury in developmental neurotoxicity. In: Reproductive and Developmental Toxicology. Elsevier; 2017:1051–1061.
   Google Scholar
• DiSabato DJ, Quan N, Godbout JP. Neuroinflammation: the devil is in the details. J Neurochem. 2016;139:136–153. doi:10.1111/jnc.13607
   PubMed Web of Science ®Google Scholar
• Fricker M, Tolkovsky AM, Borutaite V, Coleman M, Brown GC. Neuronal cell death. Physiol Rev. 2018;98(2):813–880. doi:10.1152/physrev.00011.2017
   PubMed Web of Science ®Google Scholar
• Abbaszadeh F, Fakhri S, Khan H. Targeting apoptosis and autophagy following spinal cord injury: therapeutic approaches to polyphenols and candidate phytochemicals. Pharmacol Res. 2020;160:105069. doi:10.1016/j.phrs.2020.105069
   PubMed Web of Science ®Google Scholar
• Ayaz M, Sadiq A, Junaid M, Ullah F, Subhan F, Ahmed J. Neuroprotective and anti-aging potentials of essential oils from aromatic and medicinal plants. Front Aging Neurosci. 2017;9:168.
   PubMed Web of Science ®Google Scholar
• Nowacek A, Kosloski LM, Gendelman HE. Neurodegenerative disorders and nanoformulated drug development. Nanomedicine. 2009;4(5):541–555. doi:10.2217/nnm.09.37
   PubMed Web of Science ®Google Scholar
• Re F, Gregori M, Masserini M. Nanotechnology for neurodegenerative disorders. Maturitas. 2012;73(1):45–51. doi:10.1016/j.maturitas.2011.12.015
   PubMed Web of Science ®Google Scholar
• Wilson B, Geetha KM. Neurotherapeutic applications of nanomedicine for treating Alzheimer’s disease. J Control Release. 2020;325:25–37. doi:10.1016/j.jconrel.2020.05.044
   PubMed Web of Science ®Google Scholar
• Sim TM, Tarini D, Dheen ST, Bay BH, Srinivasan DK. Nanoparticle-based technology approaches to the management of neurological disorders. Int J Mol Sci. 2020;21(17):6070. doi:10.3390/ijms21176070
   PubMed Web of Science ®Google Scholar
• Babazadeh A, Vahed FM, Jafari SM. Nanocarrier-mediated brain delivery of bioactives for treatment/prevention of neurodegenerative diseases. J Control Release. 2020;321:211–221. doi:10.1016/j.jconrel.2020.02.015
   PubMed Web of Science ®Google Scholar
• Wang G, Rayner S, Chung R, Shi B, Liang X. Advances in nanotechnology-based strategies for the treatments of amyotrophic lateral sclerosis. Mater Today Bio. 2020;6:100055. doi:10.1016/j.mtbio.2020.100055
   PubMedGoogle Scholar
• Ahmadi M, Agah E, Nafissi S, et al. Safety and efficacy of nanocurcumin as add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a pilot randomized clinical trial. Neurotherapeutics. 2018;15(2):430–438. doi:10.1007/s13311-018-0606-7
   PubMed Web of Science ®Google Scholar
• Mutoh T, Mutoh T, Taki Y, Ishikawa T. Therapeutic potential of natural product-based oral nanomedicines for stroke prevention. J Med Food. 2016;19(6):521–527. doi:10.1089/jmf.2015.3644
   PubMed Web of Science ®Google Scholar
• Bernardo-Castro S, Albino I, Barrera-Sandoval ÁM, et al. Therapeutic nanoparticles for the different phases of ischemic stroke. Life. 2021;11(6):482. doi:10.3390/life11060482
   PubMedGoogle Scholar
• Sarmah D, Saraf J, Kaur H, et al. Stroke management: an emerging role of nanotechnology. Micromachines. 2017;8(9):262.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Li Z, Zhu H, Gu Z, Zhang H, Luo K. Recent advances in nanomedicines for multiple sclerosis therapy. ACS Appl Bio Mater. 2020;3(10):6571–6597. doi:10.1021/acsabm.0c00953
   PubMedGoogle Scholar
• Mukherjee S, Madamsetty VS, Bhattacharya D, Roy Chowdhury S, Paul MK, Mukherjee A. Recent advancements of nanomedicine in neurodegenerative disorders theranostics. Adv Funct Mater. 2020;30(35):2003054. doi:10.1002/adfm.202003054
   Web of Science ®Google Scholar
• Gao H, Pang Z, Jiang X. Targeted delivery of nano-therapeutics for major disorders of the central nervous system. Pharm Res. 2013;30(10):2485–2498. doi:10.1007/s11095-013-1122-4
   PubMed Web of Science ®Google Scholar
• Asil SM, Ahlawat J, Barroso GG, Narayan M. Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases. Biomater Sci. 2020;8(15):4109–4128. doi:10.1039/D0BM00809E
   PubMed Web of Science ®Google Scholar
• Calzoni E, Cesaretti A, Polchi A, Di Michele A, Tancini B, Emiliani C. Biocompatible polymer nanoparticles for drug delivery applications in cancer and neurodegenerative disorder therapies. J Funct Biomater. 2019;10(1):4. doi:10.3390/jfb10010004
   PubMed Web of Science ®Google Scholar
• An HW, Mamuti M, Wang X, et al. Rationally Designed Modular Drug Delivery Platform Based on Intracellular Peptide Self‐assembly. Wiley Online Library; 2021:20210153.
   Google Scholar
• Zhang R, Yan X, Fan K. The advances of nanozyme in brain disease. In: Nanomedicine in Brain Diseases; 2019:139–179.
   Google Scholar
• Fakhri S, Piri S, Moradi SZ, Khan H. Phytochemicals targeting oxidative stress, interconnected neuroinflammatory and neuroapoptotic pathways following radiation. Curr Neuropharmacol. 2021;19. doi:10.2174/1570159X19666210809103346
   Web of Science ®Google Scholar
• Tee JK, Ong CN, Bay BH, Ho HK, Leong DT. Oxidative stress by inorganic nanoparticles. WIREs Nanomed Nanobiotechnol. 2016;8(3):414–438. doi:10.1002/wnan.1374
   Google Scholar
• Manke A, Wang L, Rojanasakul Y. Mechanisms of nanoparticle-induced oxidative stress and toxicity. Biomed Res Int. 2013;2013:1–15. doi:10.1155/2013/942916
   Web of Science ®Google Scholar
• Eriksson P, Tal AA, Skallberg A, et al. Cerium oxide nanoparticles with antioxidant capabilities and gadolinium integration for MRI contrast enhancement. Sci Rep. 2018;8(1):6999. doi:10.1038/s41598-018-25390-z
   PubMed Web of Science ®Google Scholar
• Caputo F, De Nicola M, Sienkiewicz A, et al. Cerium oxide nanoparticles, combining antioxidant and UV shielding properties, prevent UV-induced cell damage and mutagenesis. Nanoscale. 2015;7(38):15643–15656. doi:10.1039/C5NR03767K
   PubMed Web of Science ®Google Scholar
• Ragg R, Schilmann AM, Korschelt K, et al. Intrinsic superoxide dismutase activity of MnO nanoparticles enhances the magnetic resonance imaging contrast. J Mater Chem B. 2016;4(46):7423–7428. doi:10.1039/C6TB02078J
   PubMed Web of Science ®Google Scholar
• Niu J, Azfer A, Rogers LM, Wang X, Kolattukudy PE. Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. Cardiovasc Res. 2007;73(3):549–559. doi:10.1016/j.cardiores.2006.11.031
   PubMed Web of Science ®Google Scholar
• Yun X, Maximov VD, Yu J, Vertegel AA, Kindy MS. Nanoparticles for targeted delivery of antioxidant enzymes to the brain after cerebral ischemia and reperfusion injury. J Cereb Blood Flow Metab. 2013;33(4):583–592. doi:10.1038/jcbfm.2012.209
   PubMed Web of Science ®Google Scholar
• Xu Y, Liu H, Song L. Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review. J Nanobiotechnology. 2020;18(1):145. doi:10.1186/s12951-020-00703-5
   PubMed Web of Science ®Google Scholar
• Gil D, Rodriguez J, Ward B, Vertegel A, Ivanov V, Reukov V. Antioxidant activity of SOD and catalase conjugated with nanocrystalline ceria. Bioengineering. 2017;4(1):18. doi:10.3390/bioengineering4010018
   PubMedGoogle Scholar
• Reddy MK, Labhasetwar V. Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury. FASEB J. 2009;23(5):1384–1395. doi:10.1096/fj.08-116947
   PubMed Web of Science ®Google Scholar
• Reddy MK, Wu L, Kou W, Ghorpade A, Labhasetwar V. Superoxide dismutase-loaded PLGA nanoparticles protect cultured human neurons under oxidative stress. Appl Biochem Biotechnol. 2008;151(2):565. doi:10.1007/s12010-008-8232-1
   PubMed Web of Science ®Google Scholar
• Castellani S, Trapani A, Spagnoletta A, et al. Nanoparticle delivery of grape seed-derived proanthocyanidins to airway epithelial cells dampens oxidative stress and inflammation. J Transl Med. 2018;16(1):140. doi:10.1186/s12967-018-1509-4
   PubMed Web of Science ®Google Scholar
• Kajita M, Hikosaka K, Iitsuka M, Kanayama A, Toshima N, Miyamoto Y. Platinum nanoparticle is a useful scavenger of superoxide anion and hydrogen peroxide. Free Radic Res. 2007;41(6):615–626. doi:10.1080/10715760601169679
   PubMed Web of Science ®Google Scholar
• Mauricio MD, Guerra-Ojeda S, Marchio P, et al. Nanoparticles in medicine: a focus on vascular oxidative stress. Oxid Med Cell Longev. 2018;2018:6231482. doi:10.1155/2018/6231482
   PubMed Web of Science ®Google Scholar
• Singhal A, Morris VB, Labhasetwar V, Ghorpade A. Nanoparticle-mediated catalase delivery protects human neurons from oxidative stress. Cell Death Dis. 2013;4(11):e903–e903. doi:10.1038/cddis.2013.362
   PubMed Web of Science ®Google Scholar
• Martín R, Menchón C, Apostolova N, et al. Nano-jewels in biology. Gold and platinum on diamond nanoparticles as antioxidant systems against cellular oxidative stress. ACS Nano. 2010;4(11):6957–6965. doi:10.1021/nn1019412
   PubMed Web of Science ®Google Scholar
• Milatovic D, Zaja-Milatovic S, Breyer RM, Aschner M, Montine TJ. Chapter 64 - Neuroinflammation and oxidative injury in developmental neurotoxicity. In: Gupta RC, editor. Reproductive and Developmental Toxicology. Academic Press; 2011:847–854.
   Google Scholar
• Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005;57(2):173–185. doi:10.1124/pr.57.2.4
   PubMed Web of Science ®Google Scholar
• Shih R-H, Wang C-Y, Yang C-M. NF-kappaB signaling pathways in neurological inflammation: a mini review. Mini review. Front Mol Neurosci. 2015;8(77). doi:10.3389/fnmol.2015.00077
   PubMed Web of Science ®Google Scholar
• Kim M-H, Jeong H-J. Zinc oxide nanoparticles suppress LPS-induced NF-κB activation by inducing A20, a negative regulator of NF-κB, in RAW 264.7 macrophages. J Nanosci Nanotechnol. 2015;15(9):6509–6515. doi:10.1166/jnn.2015.10319
   PubMed Web of Science ®Google Scholar
• Kim M-H, Seo J-H, Kim H-M, Jeong H-J. Aluminum-doped zinc oxide nanoparticles attenuate the TSLP levels via suppressing caspase-1 in activated mast cells. J Biomater Appl. 2016;30(9):1407–1416. doi:10.1177/0885328216629822
   PubMed Web of Science ®Google Scholar
• Sumbayev VV, Yasinska IM, Garcia CP, et al. Gold nanoparticles downregulate interleukin‐1β‐induced pro‐inflammatory responses. Small. 2013;9(3):472–477. doi:10.1002/smll.201201528
   PubMed Web of Science ®Google Scholar
• de Carvalho TG, Garcia VB, de Araújo AA, et al. Spherical neutral gold nanoparticles improve anti-inflammatory response, oxidative stress and fibrosis in alcohol-methamphetamine-induced liver injury in rats. Int J Pharm. 2018;548(1):1–14. doi:10.1016/j.ijpharm.2018.06.008
   PubMed Web of Science ®Google Scholar
• Shaikh S, Nazam N, Danish Rizvi SM, Hussain T, Farhana A, Choi I. Anti-amyloid aggregating gold nanoparticles: can they really be translated from bench to bedside for Alzheimer’s disease treatment? Curr Protein Pept Sci. 2020;21(12):1184–1192. doi:10.2174/1389203721666200226101930
   PubMed Web of Science ®Google Scholar
• Yang T, Yao Q, Cao F, Liu Q, Liu B, Wang X-H. Silver nanoparticles inhibit the function of hypoxia-inducible factor-1 and target genes: insight into the cytotoxicity and antiangiogenesis. Int J Nanomedicine. 2016;11:6679. doi:10.2147/IJN.S109695
   PubMed Web of Science ®Google Scholar
• Sheikpranbabu S, Kalishwaralal K, Venkataraman D, Eom SH, Park J, Gurunathan S. Silver nanoparticles inhibit VEGF-and IL-1β-induced vascular permeability via Src dependent pathway in porcine retinal endothelial cells. J Nanobiotechnology. 2009;7(1):1–12. doi:10.1186/1477-3155-7-8
   PubMedGoogle Scholar
• Jang S, Park JW, Cha HR, et al. Silver nanoparticles modify VEGF signaling pathway and mucus hypersecretion in allergic airway inflammation. Int J Nanomedicine. 2012;7:1329. doi:10.2147/IJN.S27159
   PubMed Web of Science ®Google Scholar
• Franková J, Pivodová V, Vágnerová H, Juráňová J, Ulrichová J. Effects of silver nanoparticles on primary cell cultures of fibroblasts and keratinocytes in a wound-healing model. J Appl Biomater Funct Mater. 2016;14(2):137–142. doi:10.5301/jabfm.5000268
   PubMed Web of Science ®Google Scholar
• Zhu C, Zhang S, Song C, et al. Selenium nanoparticles decorated with Ulva lactuca polysaccharide potentially attenuate colitis by inhibiting NF-κB mediated hyper inflammation. J Nanobiotechnol. 2017;15(1):1–15. doi:10.1186/s12951-017-0252-y
   PubMed Web of Science ®Google Scholar
• Seisenbaeva GA, Fromell K, Vinogradov VV, et al. Dispersion of TiO 2 nanoparticles improves burn wound healing and tissue regeneration through specific interaction with blood serum proteins. Sci Rep. 2017;7(1):1–11. doi:10.1038/s41598-017-15792-w
   PubMed Web of Science ®Google Scholar
• Fiorani L, Passacantando M, Santucci S, Di Marco S, Bisti S, Maccarone R. Cerium oxide nanoparticles reduce microglial activation and neurodegenerative events in light damaged retina. PLoS One. 2015;10(10):e0140387. doi:10.1371/journal.pone.0140387
   PubMed Web of Science ®Google Scholar
• Xue J, Liu T, Liu Y, et al. Neuroprotective effect of biosynthesised gold nanoparticles synthesised from root extract of Paeonia moutan against Parkinson disease – in vitro & In vivo model. J Photochem Photobiol B. 2019;200:111635. doi:10.1016/j.jphotobiol.2019.111635
   PubMed Web of Science ®Google Scholar
• Park SY, Yi EH, Kim Y, Park G. Anti-neuroinflammatory effects of Ephedra sinica Stapf extract-capped gold nanoparticles in microglia. Int J Nanomedicine. 2019;14:2861. doi:10.2147/IJN.S195218
   PubMed Web of Science ®Google Scholar
• Murad U, Khan SA, Ibrar M, Ullah S, Khattak U. Synthesis of silver and gold nanoparticles from leaf of Litchi chinensis and its biological activities. Asian Pac J Trop Biomed. 2018;8(3):142. doi:10.4103/2221-1691.227995
   Web of Science ®Google Scholar
• Govindappa M, Hemashekhar B, Arthikala M-K, Ravishankar Rai V, Ramachandra YL. Characterization, antibacterial, antioxidant, antidiabetic, anti-inflammatory and antityrosinase activity of green synthesized silver nanoparticles using Calophyllum tomentosum leaves extract. Results Phys. 2018;9:400–408. doi:10.1016/j.rinp.2018.02.049
   Web of Science ®Google Scholar
• Erjaee H, Nazifi S, Rajaian H. Effect of Ag-NPs synthesised by Chamaemelum nobile extract on the inflammation and oxidative stress induced by carrageenan in mice paw. IET Nanobiotechnol. 2017;11(6):695–701. doi:10.1049/iet-nbt.2016.0245
   Web of Science ®Google Scholar
• Muniyappan N, Nagarajan NS. Green synthesis of silver nanoparticles with Dalbergia spinosa leaves and their applications in biological and catalytic activities. Process Biochem. 2014;49(6):1054–1061. doi:10.1016/j.procbio.2014.03.015
   Web of Science ®Google Scholar
• David L, Moldovan B, Vulcu A, et al. Green synthesis, characterization and anti-inflammatory activity of silver nanoparticles using European black elderberry fruits extract. Colloids Surf B Biointerfaces. 2014;122:767–777. doi:10.1016/j.colsurfb.2014.08.018
   PubMed Web of Science ®Google Scholar
• Mohamed El-Rafie H, Abdel-Aziz Hamed M. Antioxidant and anti-inflammatory activities of silver nanoparticles biosynthesized from aqueous leaves extracts of four Terminalia species. Adv Nat Sci: Nanosci Nanotechnol. 2014;5(3):035008. doi:10.1088/2043-6262/5/3/035008
   Web of Science ®Google Scholar
• Wang Y, Li S-Y, Shen S, Wang J. Protecting neurons from cerebral ischemia/reperfusion injury via nanoparticle-mediated delivery of an siRNA to inhibit microglial neurotoxicity. Biomaterials. 2018;161:95–105. doi:10.1016/j.biomaterials.2018.01.039
   PubMed Web of Science ®Google Scholar
• Yuan X, Fu Z, Ji P, et al. Selenium nanoparticles pre-treatment reverse behavioral, oxidative damage, neuronal loss and neurochemical alterations in pentylenetetrazole-induced epileptic seizures in mice. Int J Nanomedicine. 2020;15:6339. doi:10.2147/IJN.S259134
   PubMed Web of Science ®Google Scholar
• Andrabi SS, Yang J, Gao Y, Kuang Y, Labhasetwar V. Nanoparticles with antioxidant enzymes protect injured spinal cord from neuronal cell apoptosis by attenuating mitochondrial dysfunction. J Control Release. 2020;317:300–311. doi:10.1016/j.jconrel.2019.12.001
   PubMed Web of Science ®Google Scholar
• Nazarian S, Abdolmaleki Z, Torfeh A, Beheshtiha SHS. Mesenchymal stem cells with modafinil (gold nanoparticles) significantly improves neurological deficits in rats after middle cerebral artery occlusion. Exp Brain Res. 2020;238(11):2589–2601. doi:10.1007/s00221-020-05913-9
   PubMed Web of Science ®Google Scholar
• Petro M, Jaffer H, Yang J, Kabu S, Morris VB, Labhasetwar V. Tissue plasminogen activator followed by antioxidant-loaded nanoparticle delivery promotes activation/mobilization of progenitor cells in infarcted rat brain. Biomaterials. 2016;81:169–180. doi:10.1016/j.biomaterials.2015.12.009
   PubMed Web of Science ®Google Scholar
• Küçükdoğru R, Türkez H, Arslan ME, et al. Neuroprotective effects of boron nitride nanoparticles in the experimental Parkinson’s disease model against MPP+ induced apoptosis. Metab Brain Dis. 2020;35(6):947–957. doi:10.1007/s11011-020-00559-6
   PubMed Web of Science ®Google Scholar
• Puzzo D, Gulisano W, Palmeri A, Arancio O. Rodent models for Alzheimer’s disease drug discovery. Expert Opin Drug Discov. 2015;10(7):703–711. doi:10.1517/17460441.2015.1041913
   PubMed Web of Science ®Google Scholar
• Espay AJ, Vizcarra JA, Marsili L, et al. Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases. Neurology. 2019;92(7):329–337. doi:10.1212/WNL.0000000000006926
   PubMed Web of Science ®Google Scholar
• Khanam H, Ali A, Asif M. Neurodegenerative diseases linked to misfolded proteins and their therapeutic approaches: a review. Eur J Med Chem. 2016;124:1121–1141. doi:10.1016/j.ejmech.2016.08.006
   PubMed Web of Science ®Google Scholar
• Jiang T, Yu J-T, Tian Y, Tan L. Epidemiology and etiology of Alzheimer’s disease: from genetic to non-genetic factors. Curr Alzheimer Res. 2013;10(8):852–867. doi:10.2174/15672050113109990155
   PubMed Web of Science ®Google Scholar
• Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid β-peptide. Nat Rev Mol Cell Biol. 2007;8(2):101–112. doi:10.1038/nrm2101
   PubMed Web of Science ®Google Scholar
• Iwai A, Masliah E, Yoshimoto M, et al. The precursor protein of non-Aβ component of Alzheimer’s disease amyloid is a presynaptic protein of the central nervous system. Neuron. 1995;14(2):467–475. doi:10.1016/0896-6273(95)90302-X
   PubMed Web of Science ®Google Scholar
• Singleton A, Farrer M, Johnson J, et al. [alpha]-synuclein locus triplication causes Parkinson’s disease. science. 2003;302(5646):841–842. doi:10.1126/science.1090278
   PubMed Web of Science ®Google Scholar
• Sontheimer H. Diseases of the Nervous System. Academic Press; 2015.
   Google Scholar
• Wingo TS, Cutler DJ, Yarab N, Kelly CM, Glass JD. The heritability of amyotrophic lateral sclerosis in a clinically ascertained United States research registry. PLoS One. 2011;6(11):e27985. doi:10.1371/journal.pone.0027985
   PubMed Web of Science ®Google Scholar
• Battistini S, Ricci C, Lotti EM, et al. Severe familial ALS with a novel exon 4 mutation (L106F) in the SOD1 gene. J Neurol Sci. 2010;293(1–2):112–115. doi:10.1016/j.jns.2010.03.009
   PubMed Web of Science ®Google Scholar
• Parakh S, Atkin JD. Protein folding alterations in amyotrophic lateral sclerosis. Brain Res. 2016;1648:633–649. doi:10.1016/j.brainres.2016.04.010
   PubMed Web of Science ®Google Scholar
• Robberecht W, Philips T. The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci. 2013;14(4):248–264. doi:10.1038/nrn3430
   PubMed Web of Science ®Google Scholar
• Sweeney P, Park H, Baumann M, et al. Protein misfolding in neurodegenerative diseases: implications and strategies. Transl Neurodegener. 2017;6(1):6. doi:10.1186/s40035-017-0077-5
   PubMed Web of Science ®Google Scholar
• Gonzalez-Garcia M, Fusco G, De Simone A. Membrane interactions and toxicity by misfolded protein oligomers. Review. Front Cell Dev Biol. 2021;9(395). doi:10.3389/fcell.2021.642623
   PubMed Web of Science ®Google Scholar
• Folch J, Ettcheto M, Petrov D, et al. Review of the advances in treatment for Alzheimer disease: strategies for combating β-amyloid protein. Neurología (English Edition). 2018;33(1):47–58. doi:10.1016/j.nrleng.2015.03.019
   PubMed Web of Science ®Google Scholar
• Yang W, Wang L, Mettenbrink EM, DeAngelis PL, Wilhelm S. Nanoparticle toxicology. Annu Rev Pharmacol Toxicol. 2021;61(1):269–289. doi:10.1146/annurev-pharmtox-032320-110338
   PubMed Web of Science ®Google Scholar
• Rivera Gil P, Oberdörster G, Elder A, Puntes V, Parak WJ. Correlating physico-chemical with toxicological properties of nanoparticles: the present and the future. ACS Nano. 2010;4(10):5527–5531. doi:10.1021/nn1025687
   PubMed Web of Science ®Google Scholar
• Elsaesser A, Howard CV. Toxicology of nanoparticles. Adv Drug Deliv Rev. 2012;64(2):129–137. doi:10.1016/j.addr.2011.09.001
   PubMed Web of Science ®Google Scholar
• Fu PP, Xia Q, Hwang H-M, Ray PC, Yu H. Mechanisms of nanotoxicity: generation of reactive oxygen species. J Food Drug Anal. 2014;22(1):64–75. doi:10.1016/j.jfda.2014.01.005
   PubMed Web of Science ®Google Scholar
• Chen KL, Bothun GD. Nanoparticles Meet Cell Membranes: Probing Nonspecific Interactions Using Model Membranes. ACS Publications; 2014.
   Google Scholar
• Nel A, Xia T, Mädler L, Li N. Toxic potential of materials at the nanolevel. science. 2006;311(5761):622–627. doi:10.1126/science.1114397
   PubMed Web of Science ®Google Scholar
• Abdal Dayem A, Hossain MK, Lee SB, et al. The role of reactive oxygen species (ROS) in the biological activities of metallic nanoparticles. Int J Mol Sci. 2017;18(1):120. doi:10.3390/ijms18010120
   PubMed Web of Science ®Google Scholar
• Xia T, Kovochich M, Brant J, et al. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett. 2006;6(8):1794–1807. doi:10.1021/nl061025k
   PubMed Web of Science ®Google Scholar
• Teleanu DM, Chircov C, Grumezescu AM, Teleanu RI. Neurotoxicity of nanomaterials: an up-to-date overview. Nanomaterials (Basel). 2019;9(1):96. doi:10.3390/nano9010096
   PubMedGoogle Scholar
• Yuan ZY, Hu YL, Gao JQ. Brain localization and neurotoxicity evaluation of polysorbate 80-modified chitosan nanoparticles in rats. PLoS One. 2015;10(8):e0134722. doi:10.1371/journal.pone.0134722
   PubMed Web of Science ®Google Scholar
• Huo T, Barth RF, Yang W, et al. Preparation, biodistribution and neurotoxicity of liposomal cisplatin following convection enhanced delivery in normal and F98 glioma bearing rats. PLoS One. 2012;7(11):e48752–e48752. doi:10.1371/journal.pone.0048752
   PubMed Web of Science ®Google Scholar
• Zeng Y, Kurokawa Y, Win-Shwe TT, et al. Effects of PAMAM dendrimers with various surface functional groups and multiple generations on cytotoxicity and neuronal differentiation using human neural progenitor cells. J Toxicol Sci. 2016;41(3):351–370. doi:10.2131/jts.41.351
   PubMed Web of Science ®Google Scholar
• Yarjanli Z, Ghaedi K, Esmaeili A, Rahgozar S, Zarrabi A. Iron oxide nanoparticles may damage to the neural tissue through iron accumulation, oxidative stress, and protein aggregation. BMC Neurosci. 2017;18(1):51. doi:10.1186/s12868-017-0369-9
   PubMed Web of Science ®Google Scholar
• Sun C, Yin N, Wen R, et al. Silver nanoparticles induced neurotoxicity through oxidative stress in rat cerebral astrocytes is distinct from the effects of silver ions. Neurotoxicology. 2016;52:210–221. doi:10.1016/j.neuro.2015.09.007
   PubMed Web of Science ®Google Scholar
• You R, Ho Y-S, Hung CH-L, et al. Silica nanoparticles induce neurodegeneration-like changes in behavior, neuropathology, and affect synapse through MAPK activation. Part Fibre Toxicol. 2018;15(1):28. doi:10.1186/s12989-018-0263-3
   PubMed Web of Science ®Google Scholar
• Shi B, Du X, Chen J, et al. Multifunctional hybrid nanoparticles for traceable drug delivery and intracellular microenvironment‐controlled multistage drug‐release in neurons. Small. 2017;13(20):1603966. doi:10.1002/smll.201603966
   Web of Science ®Google Scholar
• Song B, Zhang Y, Liu J, Feng X, Zhou T, Shao L. Unraveling the neurotoxicity of titanium dioxide nanoparticles: focusing on molecular mechanisms. Beilstein J Nanotechnol. 2016;7:645–654. doi:10.3762/bjnano.7.57
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang X, Wu Q, Li Y, Wang D. Translocation and neurotoxicity of CdTe quantum dots in RMEs motor neurons in nematode Caenorhabditis elegans. J Hazard Mater. 2015;283:480–489. doi:10.1016/j.jhazmat.2014.09.063
   PubMed Web of Science ®Google Scholar
• Wu T, Zhang T, Chen Y, Tang M. Research advances on potential neurotoxicity of quantum dots. J Appl Toxicol. 2016;36(3):345–351. doi:10.1002/jat.3229
   PubMed Web of Science ®Google Scholar
• Ceña V, Játiva P. Nanoparticle crossing of blood–brain barrier: a road to new therapeutic approaches to central nervous system diseases. Future Med. 2018;13(13):1513–1516.
   Google Scholar
• Saraiva C, Praça C, Ferreira R, Santos T, Ferreira L, Bernardino L. Nanoparticle-mediated brain drug delivery: overcoming blood–brain barrier to treat neurodegenerative diseases. J Control Release. 2016;235:34–47. doi:10.1016/j.jconrel.2016.05.044
   PubMed Web of Science ®Google Scholar
• Zhou Y, Peng Z, Seven ES, Leblanc RM. Crossing the blood-brain barrier with nanoparticles. J Control Release. 2018;270:290–303. doi:10.1016/j.jconrel.2017.12.015
   PubMed Web of Science ®Google Scholar
• Ding S, Khan AI, Cai X, et al. Overcoming blood–brain barrier transport: advances in nanoparticle-based drug delivery strategies. Mater Today. 2020;37:112–125. doi:10.1016/j.mattod.2020.02.001
   Web of Science ®Google Scholar
• Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx. 2005;2(1):3–14. doi:10.1602/neurorx.2.1.3
   PubMedGoogle Scholar
• Reimold I, Domke D, Bender J, Seyfried CA, Radunz H-E, Fricker G. Delivery of nanoparticles to the brain detected by fluorescence microscopy. Eur J Pharm Biopharm. 2008;70(2):627–632. doi:10.1016/j.ejpb.2008.05.007
   PubMed Web of Science ®Google Scholar
• Fornaguera C, Dols-Perez A, Caldero G, Garcia-Celma M, Camarasa J, Solans C. PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood–brain barrier. J Control Release. 2015;211:134–143. doi:10.1016/j.jconrel.2015.06.002
   PubMed Web of Science ®Google Scholar
• Sahni JK, Doggui S, Ali J, Baboota S, Dao L, Ramassamy C. Neurotherapeutic applications of nanoparticles in Alzheimer’s disease. J Control Release. 2011;152(2):208–231. doi:10.1016/j.jconrel.2010.11.033
   PubMed Web of Science ®Google Scholar
• Cerqueira SR, Ayad NG, Lee JK. Neuroinflammation treatment via targeted delivery of nanoparticles. Front Cell Neurosci. 2020;14:576037. doi:10.3389/fncel.2020.576037
   PubMed Web of Science ®Google Scholar
• Weller J, Budson A. Current understanding of Alzheimer’s disease diagnosis and treatment. F1000Research. 2018;7:1161. doi:10.12688/f1000research.14506.1
   Google Scholar
• Teixeira MI, Lopes CM, Amaral MH, Costa PC. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases. Eur J Pharm Biopharm. 2020;149:192–217. doi:10.1016/j.ejpb.2020.01.005
   PubMed Web of Science ®Google Scholar
• López ES, Machado AL, Vidal LB, González-Pizarro R, Silva AD, Souto EB. Lipid nanoparticles as carriers for the treatment of neurodegeneration associated with Alzheimer’s disease and glaucoma: present and future challenges. Curr Pharm Des. 2020;26(12):1235–1250. doi:10.2174/1381612826666200218101231
   PubMed Web of Science ®Google Scholar
• Loureiro JA, Andrade S, Duarte A, et al. Resveratrol and grape extract-loaded solid lipid nanoparticles for the treatment of Alzheimer’s disease. Molecules. 2017;22(2):277. doi:10.3390/molecules22020277
   PubMed Web of Science ®Google Scholar
• Rajput A, Bariya A, Allam A, Othman S, Butani SB. In situ nanostructured hydrogel of resveratrol for brain targeting: in vitro-in vivo characterization. Drug Deliv Transl Res. 2018;8(5):1460–1470. doi:10.1007/s13346-018-0540-6
   PubMed Web of Science ®Google Scholar
• Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807–818. doi:10.1021/mp700113r
   PubMed Web of Science ®Google Scholar
• Cheng KK, Yeung CF, Ho SW, Chow SF, Chow AH, Baum L. Highly stabilized curcumin nanoparticles tested in an in vitro blood–brain barrier model and in Alzheimer’s disease Tg2576 mice. AAPS J. 2013;15(2):324–336. doi:10.1208/s12248-012-9444-4
   PubMed Web of Science ®Google Scholar
• Mandal M, Jaiswal P, Mishra A. Role of curcumin and its nanoformulations in neurotherapeutics: a comprehensive review. J Biochem Mol Toxicol. 2020;34(6):e22478. doi:10.1002/jbt.22478
   PubMed Web of Science ®Google Scholar
• Doggui S, Sahni JK, Arseneault M, Dao L, Ramassamy C. Neuronal uptake and neuroprotective effect of curcumin-loaded PLGA nanoparticles on the human SK-N-SH cell line. J Alzheimers Dis. 2012;30(2):377–392. doi:10.3233/JAD-2012-112141
   PubMed Web of Science ®Google Scholar
• Barbara R, Belletti D, Pederzoli F, et al. Novel curcumin loaded nanoparticles engineered for blood-brain barrier crossing and able to disrupt Abeta aggregates. Int J Pharm. 2017;526(1–2):413–424. doi:10.1016/j.ijpharm.2017.05.015
   PubMed Web of Science ®Google Scholar
• Tiwari SK, Agarwal S, Seth B, et al. Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer’s disease model via canonical Wnt/β-catenin pathway. ACS Nano. 2014;8(1):76–103. doi:10.1021/nn405077y
   PubMed Web of Science ®Google Scholar
• Fan S, Zheng Y, Liu X, et al. Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer’s disease. Drug Deliv. 2018;25(1):1091–1102. doi:10.1080/10717544.2018.1461955
   PubMed Web of Science ®Google Scholar
• Lazar AN, Mourtas S, Youssef I, et al. Curcumin-conjugated nanoliposomes with high affinity for Aβ deposits: possible applications to Alzheimer disease. Nanomedicine. 2013;9(5):712–721. doi:10.1016/j.nano.2012.11.004
   PubMed Web of Science ®Google Scholar
• Md S, Gan SY, Haw YH, Ho CL, Wong S, Choudhury H. In vitro neuroprotective effects of naringenin nanoemulsion against β-amyloid toxicity through the regulation of amyloidogenesis and tau phosphorylation. Int J Biol Macromol. 2018;118:1211–1219. doi:10.1016/j.ijbiomac.2018.06.190
   PubMed Web of Science ®Google Scholar
• Puerta E, Suárez-Santiago JE, Santos-Magalhães NS, Ramirez MJ, Irache JM. Effect of the oral administration of nanoencapsulated quercetin on a mouse model of Alzheimer’s disease. Int J Pharm. 2017;517(1–2):50–57. doi:10.1016/j.ijpharm.2016.11.061
   PubMed Web of Science ®Google Scholar
• Testa G, Gamba P, Badilli U, et al. Loading into nanoparticles improves quercetin’s efficacy in preventing neuroinflammation induced by oxysterols. PLoS One. 2014;9(5):e96795. doi:10.1371/journal.pone.0096795
   PubMed Web of Science ®Google Scholar
• Palle S, Neerati P. Quercetin nanoparticles attenuates scopolamine induced spatial memory deficits and pathological damages in rats. Bull Fac Pharm Cairo Univ. 2017;55(1):101–106. doi:10.1016/j.bfopcu.2016.10.004
   Google Scholar
• Sun D, Li N, Zhang W, et al. Design of PLGA-functionalized quercetin nanoparticles for potential use in Alzheimer’s disease. Colloids Surf B Biointerfaces. 2016;148:116–129. doi:10.1016/j.colsurfb.2016.08.052
   PubMed Web of Science ®Google Scholar
• Kuo Y-C, Rajesh R. Targeted delivery of rosmarinic acid across the blood–brain barrier for neuronal rescue using polyacrylamide-chitosan-poly (lactide-co-glycolide) nanoparticles with surface cross-reacting material 197 and apolipoprotein E. Int J Pharm. 2017;528(1–2):228–241. doi:10.1016/j.ijpharm.2017.05.039
   PubMed Web of Science ®Google Scholar
• Smith A, Giunta B, Bickford PC, Fountain M, Tan J, Shytle RD. Nanolipidic particles improve the bioavailability and α-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer’s disease. Int J Pharm. 2010;389(1–2):207–212. doi:10.1016/j.ijpharm.2010.01.012
   PubMed Web of Science ®Google Scholar
• Singh NA, Mandal AKA, Khan ZA. Inhibition of Al (III)-induced Aβ 42 fibrillation and reduction of neurotoxicity by epigallocatechin-3-gallate nanoparticles. J Biomed Nanotechnol. 2018;14(6):1147–1158. doi:10.1166/jbn.2018.2552
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhou X, Yu Q, et al. Epigallocatechin-3-gallate (EGCG)-stabilized selenium nanoparticles coated with Tet-1 peptide to reduce amyloid-β aggregation and cytotoxicity. ACS Appl Mater Interfaces. 2014;6(11):8475–8487. doi:10.1021/am501341u
   PubMed Web of Science ®Google Scholar
• Parihar VK, Prabhakar K, Veerapur VP, et al. Effect of sesamol on radiation-induced cytotoxicity in Swiss albino mice. Mutat Res Genet Toxicol Environ Mutagen. 2006;611(1–2):9–16. doi:10.1016/j.mrgentox.2006.06.037
   PubMed Web of Science ®Google Scholar
• Sachdeva AK, Misra S, Kaur IP, Chopra K. Neuroprotective potential of sesamol and its loaded solid lipid nanoparticles in ICV-STZ-induced cognitive deficits: behavioral and biochemical evidence. Eur J Pharmacol. 2015;747:132–140. doi:10.1016/j.ejphar.2014.11.014
   PubMed Web of Science ®Google Scholar
• Cai Z, Wang C, Yang W. Role of berberine in Alzheimer’s disease. Neuropsychiatr Dis Treat. 2016;12:2509. doi:10.2147/NDT.S114846
   PubMed Web of Science ®Google Scholar
• Lohan S, Raza K, Mehta S, Bhatti GK, Saini S, Singh B. Anti-Alzheimer’s potential of berberine using surface decorated multi-walled carbon nanotubes: a preclinical evidence. Int J Pharm. 2017;530(1–2):263–278. doi:10.1016/j.ijpharm.2017.07.080
   PubMed Web of Science ®Google Scholar
• Meng Q, Wang A, Hua H, et al. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer’s disease. Int J Nanomedicine. 2018;13:705. doi:10.2147/IJN.S151474
   PubMed Web of Science ®Google Scholar
• Aalinkeel R, Kutscher HL, Singh A, et al. Neuroprotective effects of a biodegradable poly (lactic-co-glycolic acid)-ginsenoside Rg3 nanoformulation: a potential nanotherapy for Alzheimer’s disease? J Drug Target. 2018;26(2):182–193. doi:10.1080/1061186X.2017.1354002
   PubMed Web of Science ®Google Scholar
• Dara T, Vatanara A, Meybodi MN, et al. Erythropoietin-loaded solid lipid nanoparticles: preparation, optimization, and in vivo evaluation. Colloids Surf B Biointerfaces. 2019;178:307–316. doi:10.1016/j.colsurfb.2019.01.027
   PubMed Web of Science ®Google Scholar
• Ismail MF, ElMeshad AN, Salem NA-H. Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer’s disease. Int J Nanomedicine. 2013;8:393. doi:10.2147/IJN.S39232
   PubMed Web of Science ®Google Scholar
• Shah B, Khunt D, Bhatt H, Misra M, Padh H. Application of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: effect on formulation and characterization parameters. Eur J Pharm Sci. 2015;78:54–66. doi:10.1016/j.ejps.2015.07.002
   PubMed Web of Science ®Google Scholar
• Al Asmari AK, Ullah Z, Tariq M, Fatani A. Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil. Drug Des Devel Ther. 2016;10:205. doi:10.2147/DDDT.S93937
   PubMedGoogle Scholar
• Misra S, Chopra K, Sinha V, Medhi B. Galantamine-loaded solid–lipid nanoparticles for enhanced brain delivery: preparation, characterization, in vitro and in vivo evaluations. Drug Deliv. 2016;23(4):1434–1443. doi:10.3109/10717544.2015.1089956
   PubMed Web of Science ®Google Scholar
• Sánchez-López E, Ettcheto M, Egea MA, et al. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization. J Nanobiotechnology. 2018;16(1):1–16. doi:10.1186/s12951-018-0356-z
   PubMed Web of Science ®Google Scholar
• Jamshed N, Ozair FF, Aggarwal P, Ekka M. Alzheimer disease in post-menopausal women: intervene in the critical window period. J Midlife Health. 2014;5(1):38. doi:10.4103/0976-7800.127791
   PubMedGoogle Scholar
• Mittal G, Carswell H, Brett R, Currie S, Kumar MR. Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer’s pathology. J Control Release. 2011;150(2):220–228. doi:10.1016/j.jconrel.2010.11.013
   PubMed Web of Science ®Google Scholar
• Wilcock GK, Black SE, Hendrix SB, et al. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer’s disease: a randomised phase II trial. Lancet Neurol. 2008;7(6):483–493. doi:10.1016/S1474-4422(08)70090-5
   PubMed Web of Science ®Google Scholar
• Muntimadugu E, Dhommati R, Jain A, Challa VGS, Shaheen M, Khan W. Intranasal delivery of nanoparticle encapsulated tarenflurbil: a potential brain targeting strategy for Alzheimer’s disease. Eur J Pharm Sci. 2016;92:224–234. doi:10.1016/j.ejps.2016.05.012
   PubMed Web of Science ®Google Scholar
• Poovaiah N, Davoudi Z, Peng H, et al. Treatment of neurodegenerative disorders through the blood-brain barrier using nanocarriers. Nanoscale. 2018;10(36):16962–16983. doi:10.1039/c8nr04073g
   PubMed Web of Science ®Google Scholar
• Zhang C, Chen J, Feng C, et al. Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer’s disease. Int J Pharm. 2014;461(1–2):192–202. doi:10.1016/j.ijpharm.2013.11.049
   PubMed Web of Science ®Google Scholar
• Fakhri S, Abdian S, Zarneshan SN, Akkol EK, Farzaei MH, Sobarzo-Sánchez E. Targeting mitochondria by plant secondary metabolites: a promising strategy in combating Parkinson’s disease. Int J Mol Sci. 2021;22(22):12570. doi:10.3390/ijms222212570
   PubMed Web of Science ®Google Scholar
• Palle S, Neerati P. Improved neuroprotective effect of resveratrol nanoparticles as evinced by abrogation of rotenone-induced behavioral deficits and oxidative and mitochondrial dysfunctions in rat model of Parkinson’s disease. Naunyn Schmiedebergs Arch Pharmacol. 2018;391(4):445–453. doi:10.1007/s00210-018-1474-8
   PubMed Web of Science ®Google Scholar
• Wang M, Li L, Zhang X, et al. Magnetic resveratrol liposomes as a new theranostic platform for magnetic resonance imaging guided Parkinson’s disease targeting therapy. ACS Sustain Chem Eng. 2018;6(12):17124–17133. doi:10.1021/acssuschemeng.8b04507
   Web of Science ®Google Scholar
• Pangeni R, Sharma S, Mustafa G, Ali J, Baboota S. Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson’s disease by reducing oxidative stress. Nanotechnology. 2014;25(48):485102. doi:10.1088/0957-4484/25/48/485102
   PubMed Web of Science ®Google Scholar
• da Rocha Lindner G, Bonfanti Santos D, Colle D, et al. Improved neuroprotective effects of resveratrol-loaded polysorbate 80-coated poly (lactide) nanoparticles in MPTP-induced Parkinsonism. Nanomedicine. 2015;10(7):1127–1138. doi:10.2217/nnm.14.165
   PubMed Web of Science ®Google Scholar
• Kundu P, Das M, Tripathy K, Sahoo SK. Delivery of dual drug loaded lipid based nanoparticles across the blood–brain barrier impart enhanced neuroprotection in a rotenone induced mouse model of Parkinson’s disease. ACS Chem Neurosci. 2016;7(12):1658–1670. doi:10.1021/acschemneuro.6b00207
   PubMed Web of Science ®Google Scholar
• Gaba B, Khan T, Haider MF, et al. Vitamin E loaded naringenin nanoemulsion via intranasal delivery for the management of oxidative stress in a 6-OHDA Parkinson’s disease model. Biomed Res Int. 2019;2019:1–20. doi:10.1155/2019/2382563
   Web of Science ®Google Scholar
• Burgos RA, Alarcón P, Quiroga J, Manosalva C, Hancke J. Andrographolide, an anti-inflammatory multitarget drug: all roads lead to cellular metabolism. Molecules. 2020;26(1):5. doi:10.3390/molecules26010005
   PubMed Web of Science ®Google Scholar
• Md S, Khan RA, Mustafa G, et al. Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model. Eur J Pharm Sci. 2013;48(3):393–405. doi:10.1016/j.ejps.2012.12.007
   PubMed Web of Science ®Google Scholar
• Yang X, Zheng R, Cai Y, Liao M, Yuan W, Liu Z. Controlled-release levodopa methyl ester/benserazide-loaded nanoparticles ameliorate levodopa-induced dyskinesia in rats. Int J Nanomedicine. 2012;7:2077. doi:10.2147/IJN.S30463
   PubMed Web of Science ®Google Scholar
• Lim JH, Kim SS, Boo DH, et al. Protective effect of bromocriptine against BH4-induced Cath. a cell death involving up-regulation of antioxidant enzymes. Neurosci Lett. 2009;451(3):185–189.
   PubMed Web of Science ®Google Scholar
• Esposito E, Fantin M, Marti M, et al. Solid lipid nanoparticles as delivery systems for bromocriptine. Pharm Res. 2008;25(7):1521–1530. doi:10.1007/s11095-007-9514-y
   PubMed Web of Science ®Google Scholar
• Barcia E, Boeva L, García-García L, et al. Nanotechnology-based drug delivery of ropinirole for Parkinson’s disease. Drug Deliv. 2017;24(1):1112–1123. doi:10.1080/10717544.2017.1359862
   PubMed Web of Science ®Google Scholar
• Fukuzaki K, Kamenosono T, Nagata R. Effects of ropinirole on various parkinsonian models in mice, rats, and cynomolgus monkeys. Pharmacol Biochem Behav. 2000;65(3):503–508. doi:10.1016/S0091-3057(99)00240-3
   PubMed Web of Science ®Google Scholar
• Pardeshi CV, Belgamwar VS, Tekade AR, Surana SJ. Novel surface modified polymer–lipid hybrid nanoparticles as intranasal carriers for ropinirole hydrochloride: in vitro, ex vivo and in vivo pharmacodynamic evaluation. J Mater Sci Mater Med. 2013;24(9):2101–2115. doi:10.1007/s10856-013-4965-7
   PubMed Web of Science ®Google Scholar
• Raj R, Wairkar S, Sridhar V, Gaud R. Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: development, characterization and in vivo anti-Parkinson activity. Int J Biol Macromol. 2018;109:27–35. doi:10.1016/j.ijbiomac.2017.12.056
   PubMed Web of Science ®Google Scholar
• Subramony JA. Apomorphine in dopaminergic therapy. Mol Pharm. 2006;3(4):380–385. doi:10.1021/mp060012c
   PubMed Web of Science ®Google Scholar
• Tsai M-J, Huang Y-B, Wu P-C, et al. Oral apomorphine delivery from solid lipid nanoparticles with different monostearate emulsifiers: pharmacokinetic and behavioral evaluations. J Pharm Sci. 2011;100(2):547–557. doi:10.1002/jps.22285
   PubMed Web of Science ®Google Scholar
• Kumar S, Dang S, Nigam K, Ali J, Baboota S. Selegiline nanoformulation in attenuation of oxidative stress and upregulation of dopamine in the brain for the treatment of Parkinson’s disease. Rejuvenation Res. 2018;21(5):464–476. doi:10.1089/rej.2017.2035
   PubMed Web of Science ®Google Scholar
• Kumar S, Ali J, Baboota S. Design Expert® supported optimization and predictive analysis of selegiline nanoemulsion via the olfactory region with enhanced behavioural performance in Parkinson’s disease. Nanotechnology. 2016;27(43):435101. doi:10.1088/0957-4484/27/43/435101
   PubMed Web of Science ®Google Scholar
• Rinaldi F, Seguella L, Gigli S, et al. inPentasomes: an innovative nose-to-brain pentamidine delivery blunts MPTP parkinsonism in mice. J Control Release. 2019;294:17–26. doi:10.1016/j.jconrel.2018.12.007
   PubMed Web of Science ®Google Scholar
• Velander P, Wu L, Henderson F, Zhang S, Bevan DR, Xu B. Natural product-based amyloid inhibitors. Biochem Pharmacol. 2017;139:40–55. doi:10.1016/j.bcp.2017.04.004
   PubMed Web of Science ®Google Scholar
• Bondi M, Montana G, Craparo E, et al. Ferulic acid-loaded lipid nanostructures as drug delivery systems for Alzheimer’s disease: preparation, characterization and cytotoxicity studies. Curr Nanosci. 2009;5(1):26–32. doi:10.2174/157341309787314656
   Web of Science ®Google Scholar
• Mohammad-Beigi H, Morshedi D, Shojaosadati SA, et al. Gallic acid loaded onto polyethylenimine-coated human serum albumin nanoparticles (PEI-HSA-GA NPs) stabilizes α-synuclein in the unfolded conformation and inhibits aggregation. RSC Adv. 2016;6(88):85312–85323.
   Web of Science ®Google Scholar
• Wang J, Xu G, Gonzales V, et al. Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site. Neurobiol Dis. 2002;10(2):128–138. doi:10.1006/nbdi.2002.0498
   PubMed Web of Science ®Google Scholar
• Bhatia NK, Srivastava A, Katyal N, et al. Curcumin binds to the pre-fibrillar aggregates of Cu/Zn superoxide dismutase (SOD1) and alters its amyloidogenic pathway resulting in reduced cytotoxicity. Biochim Biophys Acta Proteins Proteom. 2015;1854(5):426–436. doi:10.1016/j.bbapap.2015.01.014
   PubMed Web of Science ®Google Scholar
• Tripodo G, Chlapanidas T, Perteghella S, et al. Mesenchymal stromal cells loading curcumin-INVITE-micelles: a drug delivery system for neurodegenerative diseases. Colloids Surf B Biointerfaces. 2015;125:300–308. doi:10.1016/j.colsurfb.2014.11.034
   PubMed Web of Science ®Google Scholar
• Rothstein JD. Edaravone: a new drug approved for ALS. Cell. 2017;171(4):725. doi:10.1016/j.cell.2017.10.011
   PubMed Web of Science ®Google Scholar
• Yang T, Ferrill L, Gallant L, et al. Verapamil and riluzole cocktail liposomes overcome pharmacoresistance by inhibiting P-glycoprotein in brain endothelial and astrocyte cells: a potent approach to treat amyotrophic lateral sclerosis. Eur J Pharm Sci. 2018;120:30–39. doi:10.1016/j.ejps.2018.04.026
   PubMed Web of Science ®Google Scholar
• Silva Adaya D, Aguirre-Cruz L, Guevara J, Ortiz-Islas E. Nanobiomaterials’ applications in neurodegenerative diseases. J Biomater Appl. 2017;31(7):953–984. doi:10.1177/0885328216659032
   PubMed Web of Science ®Google Scholar
• Battaglia L, Panciani PP, Muntoni E, et al. Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery. Expert Opin Drug Deliv. 2018;15(4):369–378. doi:10.1080/17425247.2018.1429401
   PubMed Web of Science ®Google Scholar
• Marcuzzo S, Isaia D, Bonanno S, et al. FM19G11-loaded gold nanoparticles enhance the proliferation and self-renewal of ependymal stem progenitor cells derived from ALS mice. Cells. 2019;8(3):279. doi:10.3390/cells8030279
   PubMed Web of Science ®Google Scholar
• Nouri Z, Fakhri S, El-Senduny FF, et al. On the neuroprotective effects of naringenin: pharmacological targets, signaling pathways, molecular mechanisms, and clinical perspective. Biomolecules. 2019;9(11):690. doi:10.3390/biom9110690
   PubMed Web of Science ®Google Scholar
• Lu X, Dong J, Zheng D, Li X, Ding D, Xu H. Reperfusion combined with intraarterial administration of resveratrol-loaded nanoparticles improved cerebral ischemia–reperfusion injury in rats. Nanomedicine. 2020;28:102208. doi:10.1016/j.nano.2020.102208
   PubMed Web of Science ®Google Scholar
• Kakkar V, Muppu SK, Chopra K, Kaur IP. Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats. Eur J Pharm Biopharm. 2013;85(3):339–345. doi:10.1016/j.ejpb.2013.02.005
   PubMed Web of Science ®Google Scholar
• Ghosh A, Sarkar S, Mandal AK, Das N. Neuroprotective role of nanoencapsulated quercetin in combating ischemia-reperfusion induced neuronal damage in young and aged rats. PLoS One. 2013;8(4):e57735. doi:10.1371/journal.pone.0057735
   PubMed Web of Science ®Google Scholar
• Ghosh S, Sarkar S, Choudhury ST, Ghosh T, Das N. Triphenyl phosphonium coated nano-quercetin for oral delivery: neuroprotective effects in attenuating age related global moderate cerebral ischemia reperfusion injury in rats. Nanomedicine. 2017;13(8):2439–2450. doi:10.1016/j.nano.2017.08.002
   PubMed Web of Science ®Google Scholar
• Zhang J, Han X, Li X, et al. Core-shell hybrid liposomal vesicles loaded with panax notoginsenoside: preparation, characterization and protective effects on global cerebral ischemia/reperfusion injury and acute myocardial ischemia in rats. Int J Nanomedicine. 2012;7:4299. doi:10.2147/IJN.S32385
   PubMed Web of Science ®Google Scholar
• Ahmad A, Fauzia E, Kumar M, et al. Gelatin-coated polycaprolactone nanoparticle-mediated naringenin delivery rescue human mesenchymal stem cells from oxygen glucose deprivation-induced inflammatory stress. ACS Biomater Sci Eng. 2018;5(2):683–695. doi:10.1021/acsbiomaterials.8b01081
   PubMed Web of Science ®Google Scholar
• Deng J, Mei H, Shi W, et al. Recombinant tissue plasminogen activator-conjugated nanoparticles effectively targets thrombolysis in a rat model of middle cerebral artery occlusion. Curr Med Sci. 2018;38(3):427–435. doi:10.1007/s11596-018-1896-z
   PubMed Web of Science ®Google Scholar
• Fukuta T, Asai T, Yanagida Y, et al. Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke. FASEB J. 2017;31(5):1879–1890. doi:10.1096/fj.201601209R
   PubMed Web of Science ®Google Scholar
• Zhu FD, Hu YJ, Yu L, et al. Nanoparticles: a hope for the treatment of inflammation in CNS. Front Pharmacol. 2021;12:683935. doi:10.3389/fphar.2021.683935
   PubMed Web of Science ®Google Scholar
• Carmeliet P. Angiogenesis in life, disease and medicine. Nature. 2005;438(7070):932–936. doi:10.1038/nature04478
   PubMed Web of Science ®Google Scholar
• George ML, Eccles SA, Tutton MG, Abulafi AM, Swift RI. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin Cancer Res. 2000;6(8):3147–3152.
   PubMed Web of Science ®Google Scholar
• Ju R, Wen Y, Gou R, Wang Y, Xu Q. The experimental therapy on brain ischemia by improvement of local angiogenesis with tissue engineering in the mouse. Cell Transplant. 2014;23(1_suppl):83–95. doi:10.3727/096368914X684998
   Web of Science ®Google Scholar
• Zhao H, Bao X-J, Wang R-Z, et al. Postacute ischemia vascular endothelial growth factor transfer by transferrin-targeted liposomes attenuates ischemic brain injury after experimental stroke in rats. Hum Gene Ther. 2011;22(2):207–215. doi:10.1089/hum.2010.111
   PubMed Web of Science ®Google Scholar
• Andre EM, Passirani C, Seijo B, Sanchez A, Montero-Menei CN. Nano and microcarriers to improve stem cell behaviour for neuroregenerative medicine strategies: application to Huntington’s disease. Biomaterials. 2016;83:347–362. doi:10.1016/j.biomaterials.2015.12.008
   PubMed Web of Science ®Google Scholar
• Maiti P, Dunbar GL. Use of curcumin, a natural polyphenol for targeting molecular pathways in treating age-related neurodegenerative diseases. Int J Mol Sci. 2018;19(6):1637. doi:10.3390/ijms19061637
   PubMed Web of Science ®Google Scholar
• Sandhir R, Yadav A, Mehrotra A, Sunkaria A, Singh A, Sharma S. Curcumin nanoparticles attenuate neurochemical and neurobehavioral deficits in experimental model of Huntington’s disease. Neuromolecular Med. 2014;16(1):106–118. doi:10.1007/s12017-013-8261-y
   PubMed Web of Science ®Google Scholar
• Pepe G, Calce E, Verdoliva V, et al. Curcumin-loaded nanoparticles based on amphiphilic hyaluronan-conjugate explored as targeting delivery system for neurodegenerative disorders. Int J Mol Sci. 2020;21(22):8846. doi:10.3390/ijms21228846
   PubMed Web of Science ®Google Scholar
• Bhatt R, Singh D, Prakash A, Mishra N. Development, characterization and nasal delivery of rosmarinic acid-loaded solid lipid nanoparticles for the effective management of Huntington’s disease. Drug Deliv. 2015;22(7):931–939. doi:10.3109/10717544.2014.880860
   PubMed Web of Science ®Google Scholar
• Dolati S, Babaloo Z, Jadidi-Niaragh F, Ayromlou H, Sadreddini S, Yousefi M. Multiple sclerosis: therapeutic applications of advancing drug delivery systems. Biomed Pharmacother. 2017;86:343–353. doi:10.1016/j.biopha.2016.12.010
   PubMed Web of Science ®Google Scholar
• Kumar P, Sharma G, Gupta V, et al. Preclinical explorative assessment of dimethyl fumarate-based biocompatible nanolipoidal carriers for the management of multiple sclerosis. ACS Chem Neurosci. 2018;9(5):1152–1158. doi:10.1021/acschemneuro.7b00519
   PubMed Web of Science ®Google Scholar
• Kumar P, Sharma G, Kumar R, et al. Vitamin-derived nanolipoidal carriers for brain delivery of dimethyl fumarate: a novel approach with preclinical evidence. ACS Chem Neurosci. 2017;8(6):1390–1396. doi:10.1021/acschemneuro.7b00041
   PubMed Web of Science ®Google Scholar
• Esposito E, Cortesi R, Drechsler M, et al. Nanoformulations for dimethyl fumarate: physicochemical characterization and in vitro/in vivo behavior. Eur J Pharm Biopharm. 2017;115:285–296. doi:10.1016/j.ejpb.2017.04.011
   PubMed Web of Science ®Google Scholar
• Yang J, Wang L, Huang L, et al. Receptor‐targeting Nanomaterials Alleviate Binge Drinking‐induced Neurodegeneration as Artificial Neurotrophins. Wiley Online Library; 2021:61–74.
   Google Scholar
• Min HS, Kim HJ, Naito M, et al. Systemic brain delivery of antisense oligonucleotides across the blood–brain barrier with a glucose‐coated polymeric nanocarrier. Angew Chem. 2020;132(21):8250–8257. doi:10.1002/ange.201914751
   Google Scholar
• Chang X, Li J, Niu S, Xue Y, Tang M. Neurotoxicity of metal‐containing nanoparticles and implications in glial cells. J Appl Toxicol. 2021;41(1):65–81. doi:10.1002/jat.4037
   PubMed Web of Science ®Google Scholar